Nkarta to Participate at Upcoming Investor Conference

Rhea-AI Summary

Nkarta, Inc. (Nasdaq: NKTX) to participate in Canaccord Genuity 43rd Annual Growth Conference on August 10, 2023, at 12:00 p.m. ET. The biopharmaceutical company will host a fireside chat, with a simultaneous webcast and 90-day replay available on their website, www.nkartatx.com.

SOUTH SAN FRANCISCO, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation at an upcoming investor conference:

Canaccord Genuity 43^rd Annual Growth Conference
August 10, 2023
12:00 p.m. ET – fireside chat

A simultaneous webcast of each event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep anti-tumor activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.  

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com

FAQ

What event is Nkarta, Inc. participating in?

Nkarta, Inc. is participating in the Canaccord Genuity 43rd Annual Growth Conference.

When is the event taking place?

The event is scheduled for August 10, 2023, at 12:00 p.m. ET.

Where can the webcast be accessed?

The webcast will be available on the Investors section of Nkarta’s website, www.nkartatx.com.

How long will the replay be available?

A replay of the event will be archived on the website for approximately 90 days.